Mark’s Gospel has intrigued scholars for years. Or maybe it has confounded them. There’s a general consensus that Jesus is Messiah and that Mark is written against a Roman backdrop, but paths diverge from there. Adam Winn takes a stab at it arguing that Jesus as Lord directly counters Roman propaganda. He further posits that Christians would have read it as such in those days. Winn explains in his acknowledgments that this is his second pass on this subject. He wrote on the Christology of Mark in his doctoral dissertation and has since imbibed the contributions of his critics. To me, this work benefits from that mature reflection.
The Introduction possesses great value as a reflection on what’s been believed along with a perceptive analysis of trends found in the text of Mark itself. The secrecy motive, redaction studies, and other criticisms good and bad are well explained too. Fortunately, he unpacks his own approach, which gives you a good basis to take in what he will share over the course of the book.
In chapter one, he reconstructs the historical setting. That analysis is foundational as he sees Roman influence as a driving force in Mark. Chapter two develops the equally essential element of his approach as he explains Christological titles in Mark. You don’t have to agree with his conclusions about the individual titles to glean from the chapter.
The next two chapters trace this theme through the traditional lens of the powerful Jesus in Mark 1-8:21 and the suffering Jesus in Mark 8:22-10:52. In chapter five he returns to the secrecy motif through his Roman lens followed by one on Christology.
If you are familiar with volumes that attempt to provide a thematic analysis of a biblical book, you will find this book to be a good representative of the type. It may be a specialized subject, but it is one well done.
I received this book free from the publisher. I was not required to write a positive review. The opinions I have expressed are my own. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255.